Publications by authors named "Marthe Minderman"

Claim this Profile
S
Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.
Patrick R G Eriksen, Fleur de Groot, Erik Clasen-Linde, Peter de Nully Brown, Ruben de Groen, Marthe Minderman

Blood Adv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain.
Marthe Minderman, Hildo Lantermans, Carmen van der Zwaan, Arie J Hoogendijk, Maartje van den Biggelaar

Blood Cancer J· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and prognostic value of and mutations in ocular adnexal large B-cell lymphoma: a reclassification of ocular adnexal large B-cell lymphoma.
Marina Knudsen Kirkegaard, Marthe Minderman, Lene Dissing Sjö, Steven T Pals, Patrick R G Eriksen

Br J Ophthalmol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas.
Marthe Minderman, Hildo C Lantermans, Leonie J Grüneberg, Saskia A G M Cillessen, Richard J Bende

Blood Cancer J· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations.
Marthe Minderman, Avital Amir, Willem Kraan, Esther J M Schilder-Tol, Monique E C M Oud

Blood· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma.
Hildo C Lantermans, Marthe Minderman, Annemieke Kuil, Marie-José Kersten, Steven T Pals

Leukemia· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards genomic-based prognostication and precision therapy for diffuse large B-cell lymphoma.
Marthe Minderman, Steven T Pals

Haematologica· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation.
Martijn H den Brok, Christian Büll, Melissa Wassink, Annemarie M de Graaf, Jori A Wagenaars, Marthe Minderman

Nat Commun· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis